Business
Veeva and BioMarin Form Long-Term Strategic Partnership
Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapiesPLEASANTON, Calif., and SAN RAFAEL, Calif.,
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapiesPLEASANTON, Calif., and SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced a long-term enterprise agreement that builds upon their long-standing relationship.\n \n \n \n \n \n \n \nThe expanded partnership will help BioMarin increase speed, agility, operational efficiency, and optimize the healthcare professional and patient experience by further leveraging and providing strategic input into Veeva's software, data, services, and consulting products.\"This strategic partnership marks an important next step in our digital evolution,\" said Alexander Hardy, President and Chief Executive Officer of BioMarin. \"We are excited by the opportunity to combine our scientific capabilities with Veeva's technological leadership that we believe will enable us to bring our transformative medicines more quickly to patients around the world.\"\"Our partnership with BioMarin has always been guided by a shared set of values, including product excellence, value realization, and customer success,\" said Veeva CEO Peter Gassner. \"Building on this foundation, I look forward to how we can further support BioMarin as they advance important new medicines and reach even more patients around the world.\"About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.About Veeva SystemsVeeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the int...